Table 1.
Treatment | Application Route | Survival at 48 h (%) | VdGSTMu knockdown (%)a |
---|---|---|---|
dsRNA in 0.9% NaCl | topical droplet | 79 (n = 14) | 0% (n = 3) |
dsRNA in 0.2% Triton-X100 | topical droplet | 0 (n = 6) | n/d |
distilled water | immersion | 0 (n = 15) | n/a |
0.2% Triton-X100 | immersion | 0 (n = 15) | n/a |
0.9% NaCl | immersion | 80 (n = 15) | n/a |
dsRNA in 0.9% NaCl | immersion | 76 (n = 21) | 87 ± 0.7% (3) |
dsRNA | injection | 50 (n = 62) | 96 ± 3.7% (4) |
a n/d, not determined; n/a, not appropriate; data presented mean ± SEM